Vimta Labs (BOM:524394) Tax Expense: ₹274 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524394 Vimta Labs Ltd BOM:524394
84 GF Score
Price ₹656.85
GF Value ₹495.16
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Vimta Labs Tax Expense?

Vimta Labs BOM:524394 +2.44% 84 Tax Expense is ₹274 Mil as of Jun. 2026. GuruFocus rates BOM:524394 with a GF Score™ of 84/100 and a GF Value™ of ₹495.16 (Significantly Overvalued). The stock has 1 warning sign investors should review.

Vimta Labs's tax expense for the months ended in Jun. 2026 was ₹73 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2026 was ₹274 Mil.


Vimta Labs  (BOM:524394) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Vimta Labs Tax Expense Related Terms


Vimta Labs Tax Expense Historical Data

* Premium members only.

The historical data trend for Vimta Labs's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vimta Labs Tax Expense Chart

Vimta Labs Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 143.55 168.25 136.93 222.45 264.41

Vimta Labs Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.68 63.54 57.85 79.34 72.96
BOM:524394
84GF Score
Vimta Labs Ltd BOM:524394
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vimta Labs Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹274 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of ₹274 Mil mean?
Vimta Labs (BOM:524394) has a Tax Expense of ₹274 Mil as of Jun. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Vimta Labs and its competitors.
Is Vimta Labs' Tax Expense too high?
Vimta Labs' current Tax Expense is ₹274 Mil. Overall, Vimta Labs has a GF Score™ of 84/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vimta Labs' Tax Expense compare to TMO and DHR?
Vimta Labs' Tax Expense of ₹274 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Diagnostics & Research company?
A good Tax Expense depends on the Medical Diagnostics & Research industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Vimta Labs and its competitors. Vimta Labs's current Tax Expense is ₹274 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vimta Labs stock overvalued right now?
Based on GuruFocus' analysis, Vimta Labs (BOM:524394) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹495.16, compared to a current price of ₹656.85 — trading 32.7% above its estimated fair value. The current Tax Expense is ₹274 Mil. Vimta Labs' overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Vimta Labs (BOM:524394), the current Tax Expense is ₹274 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Vimta Labs (BOM:524394) Overvalued in 2026?

Based on GuruFocus' analysis, Vimta Labs stock appears to be overvalued. The current stock price of ₹656.85 is trading 32.7% above its estimated GF Value™ of ₹495.16. GuruFocus considers Vimta Labs to be Significantly Overvalued.

Key valuation signals for BOM:524394:

  • Tax Expense: ₹274 Mil
  • GF Value™: ₹495.16 vs. price of ₹656.85 (32.7% above fair value)
  • GF Score™: 84/100 with 1 warning sign

No single metric tells the full story. See the BOM:524394 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Vimta Labs Business Description

Other Exchanges VIMTALABS:India
Address Plot No.141/2 & 142, IDA, Phase-II, Cherlapally, R. R. District, Hyderabad, TG, IND, 500051
Vimta Labs Ltd is a comprehensive contract research and testing organization, providing a wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device, and many other industries. Its services portfolio includes testing and contract research services in the fields of clinical research, pre-clinical research, clinical diagnostics, biopharma services, analytical testing, research and environmental studies, and Others. It has only one reportable segment namely Contract Research and Testing Services which generates the revenue.
84GF Score

Get the complete analysis for BOM:524394

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹656.85
Price
₹495.16
GF Value